High doses of the hormone progesterone can kill neuroblastoma cells while leaving healthy cells unscathed, according to results in the journal Molecular Medicine. Neuroblastoma is the most common form of cancer affecting small children. More research is necessary to determine the optimal dose, how long progesterone treatment should last and if it should be used alone or in combination with radiation or chemotherapy. Scientists are also exploring whether it can stop the growth of other brain cancer types such as glioblastoma and astrocytoma. Progesterone has also been reported to slow growth of several other types of cancers in the laboratory.
The discovery grew out of studies of progesterone's protective effects in brain injury. While investigating how to enhance progesterone's effectiveness, scientists observed that it could protect healthy neurons from stress but caused cells from a tumor cell line to die. Progesterone reduced the levels of proteins produced by tumor cells that attract new blood vessel growth and help tumor cells invade other tissues. This fits with what is known about one of progesterone's roles during pregnancy, which is to regulate the growth of placenta. Placental cells behave in a way that resembles tumor cells, invading the uterine wall and tapping into the mother's blood vessels.
No comments:
Post a Comment